NCBI PubMed NLMPubMed
My NCBI
[Sign In] [Register]
Entrez PubMed Nucleotide Protein Genome Structure OMIM PMC Journals Books
 Search for
Limits 
Preview/Index 
History 
Clipboard 
Details 
About Entrez

Text Version

Entrez PubMed
Overview
Help | FAQ
Tutorial
New/Noteworthy
E-Utilities

PubMed Services
Journals Database
MeSH Database
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
LinkOut
My NCBI (Cubby)

Related Resources
Order Documents
NLM Catalog
NLM Gateway
TOXNET
Consumer Health
Clinical Alerts
ClinicalTrials.gov
PubMed Central
 Show: 
All: 1 
Review: 0 
1: Zh Nevrol Psikhiatr Im S S Korsakova. 2001;101(12):32-6. Related Articles, Links

[Benfotiamine efficacy in alcoholic polyneuropathy therapy]

[Article in Russian]

Anisimova EI, Danilov AB.

Benfogamma efficacy in alcoholic polyneuropathy therapy with pain syndrome and other sensor disorders has been studied. Fourteen males with stage II-III chronic alcoholism (mean age 41.2 +/- 9 years, mean alcoholism duration 20.6 +/- 6 years, mean alcoholic polyneuropathy therapy duration 6.8 +/- 4.9 years) have been examined, 93% of the cases having positive family history of alcoholism. Clinical neurophysiological examination was conducted at the beginning and at the end of 6-week therapy, 450 mg/day (2 weeks) and 300 mg/day (4 weeks). During the treatment the regress of algic, other sensor and movement disorders, as well as some neuropathy symptoms has been observed. The evidence of positive dynamics at peripheral and segmental nerve system level was supported by neurophysiological data.

Publication Types:
  • Clinical Trial

PMID: 11811123 [PubMed - indexed for MEDLINE]


 Show: